News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Could Regeneron (REGN) Be The Best Biotech Stock To Buy?



8/18/2017 6:18:57 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
It may not get the attention as often as larger-cap biotech stocks like Celgene Corp. and Gilead Sciences, but a bunch of recent drug approvals could soon change that for Regeneron Pharmaceuticals. Is Regeneron Pharmaceuticals about to reward investors with a steady stream of big-time sales and profit growth?

In this episode of the Motley Fool's Industry Focus: Healthcare podcast, host Kristine Harjes is joined by Todd Campbell to explain why it could be an exciting time to become a Regeneron Pharmaceuticals shareholder.

Read at Motley Fool


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES